Authors:
Levin, VA
Uhm, JH
Jaeckle, KA
Choucair, A
Flynn, PJ
Yung, WKA
Prados, MD
Bruner, JM
Chang, SM
Kyritsis, AP
Gleason, MJ
Hess, KR
Citation: Va. Levin et al., Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazin N-(2-chloroethyl)-N '-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme, CLIN CANC R, 6(10), 2000, pp. 3878-3884
Authors:
Benson, AB
Desch, CE
Flynn, PJ
Krause, C
Loprinzi, CL
Minsky, BD
Petrelli, NJ
Pfister, DG
Smith, TJ
Somerfield, MR
Citation: Ab. Benson et al., 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines, J CL ONCOL, 18(20), 2000, pp. 3586-3588
Authors:
Pandya, KJ
Raubertas, RF
Flynn, PJ
Hynes, HE
Rosenbluth, RJ
Kirshner, JJ
Pierce, HI
Dragalin, V
Morrow, GR
Citation: Kj. Pandya et al., Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: A University of Rochester cancer center community clinical oncology program study, ANN INT MED, 132(10), 2000, pp. 788-793
Authors:
Spiegel, D
Morrow, GR
Classen, C
Raubertas, R
Stott, PB
Mudaliar, N
Pierce, HI
Flynn, PJ
Heard, L
Riggs, G
Citation: D. Spiegel et al., Group psychotherapy for recently diagnosed breast cancer patients: A multicenter feasibility study, PSYCHO-ONC, 8(6), 1999, pp. 482-493
Authors:
Desch, CE
Benson, AB
Smith, TJ
Flynn, PJ
Krause, C
Loprinzi, CL
Minsky, BD
Petrelli, NJ
Pfister, DG
Somerfield, MR
Citation: Ce. Desch et al., Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology, J CL ONCOL, 17(4), 1999, pp. 1312-1321
Authors:
McCaskill-Stevens, W
Hawk, ET
Flynn, PJ
Lippman, SM
Citation: W. Mccaskill-stevens et al., National Cancer Institute-supported cancer chemoprevention research: Coming of age, J CL ONCOL, 17(11), 1999, pp. 53-62
Citation: Pj. Flynn et Rj. Reece, Activation of transcription by metabolic intermediates of the pyrimidine biosynthetic pathway, MOL CELL B, 19(1), 1999, pp. 882-888
Authors:
Hickok, JT
Roscoe, JA
Morrow, GR
Stern, RM
Yang, B
Flynn, PJ
Hynes, HE
Kirshner, JJ
Rosenbluth, RJ
Citation: Jt. Hickok et al., Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings, CANCER, 86(1), 1999, pp. 64-71